Get started
RELIEF THERAPEUTICS NRR

RELIEF THERAPEUTICS N

No trades
See on Supercharts
Overview
Financials News Ideas Discussions Technicals Seasonals

RLF chart


Full chart

Key stats


Market capitalization
‪31.98 M‬ CHF
Dividend yield (indicated)
—
Price to earnings Ratio (TTM)
—
Basic EPS (TTM)
−1.365 CHF
Net income (FY)
‪−17.12 M‬ CHF
Revenue (FY)
‪8.42 M‬ CHF
Shares float
‪9.88 M‬
Beta (1Y)
−0.81

Employees


Employees (FY)
31
Revenue / Employee (1Y)
‪271.52 K‬ CHF
Net income / Employee (1Y)
‪−552.23 K‬ CHF

About RELIEF THERAPEUTICS N


Sector
Health Technology
Industry
Pharmaceuticals: Major
Website
relieftherapeutics.com
Headquarters
Geneva
Founded
2013
ISIN
CH1251125998
FIGI
BBG000C4NCF9
RELIEF THERAPEUTICS Holding SA is a commercial-stage biopharmaceutical company, which engages in the research, development, and commercialization of treatment for rare debilitating conditions. The firm offers Physiomimic and TEHCLO, drug delivery platform technologies and a targeted clinical development pipeline consisting of risk-mitigated assets to address rare metabolic disorders, rare skin diseases, and rare respiratory diseases. It operates through the following geographical segments: Switzerland, Europe, North America, and Rest of the World. The company was founded in 2013 and is headquartered in Geneva, Switzerland.

Financials


Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:—

RLF news



No news here

Looks like there's nothing to report right now

Reload

Ideas



See all ideas 

Technicals


Summarizing what the indicators are suggesting.
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Oscillators
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Summary
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Moving Averages
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy

Seasonals


Displays a symbol's price movements over previous years to identify recurring trends.

Frequently Asked Questions


The current price of RLF is 2.415 CHF — it has increased by 2.41% in the past 24 hours. Watch RELIEF THERAPEUTICS N stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SIX exchange RELIEF THERAPEUTICS N stocks are traded under the ticker RLF.
RLF stock has risen by 10.87% compared to the previous week, the month change is a 2.00% rise, over the last year RELIEF THERAPEUTICS N has showed a 82.95% increase.
RLF reached its all-time high on Aug 7, 2020 with the price of 320.000 CHF, and its all-time low was 0.320 CHF and was reached on Oct 30, 2019. View more price dynamics on RLF chart.
See other stocks reaching their highest and lowest prices.
RLF stock is 8.74% volatile and has beta coefficient of −0.81. Track RELIEF THERAPEUTICS N stock price on the chart and check out the list of the most volatile stocks — is RELIEF THERAPEUTICS N there?
Today RELIEF THERAPEUTICS N has the market capitalization of ‪31.98 M‬, it has increased by 12.79% over the last week.
Yes, you can track RELIEF THERAPEUTICS N financials in yearly and quarterly reports right on TradingView.
RLF net income for the last half-year is ‪−12.56 M‬ CHF, while the previous report showed ‪−4.56 M‬ CHF of net income which accounts for −175.66% change. Track more RELIEF THERAPEUTICS N financial stats to get the full picture.
No, RLF doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Apr 22, 2025, the company has 31 employees. See our rating of the largest employees — is RELIEF THERAPEUTICS N on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. RELIEF THERAPEUTICS N EBITDA is ‪−5.11 M‬ CHF, and current EBITDA margin is −60.69%. See more stats in RELIEF THERAPEUTICS N financial statements.
Like other stocks, RLF shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade RELIEF THERAPEUTICS N stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So RELIEF THERAPEUTICS N technincal analysis shows the sell today, and its 1 week rating is strong sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating RELIEF THERAPEUTICS N stock shows the sell signal. See more of RELIEF THERAPEUTICS N technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.